Insiders Compugen Ltd.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 25/06/2024 am IST			5-day change	1st Jan Change
1.87 ^USD	-5.08%		-4.59%	-5.56%

30/05	Compugen Ltd. to Receive Milestone Payment from Astrazeneca Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig	CI
20/05	Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating	MT

Compugen Names David Silberman CFO	15/05	MT
Compugen Ltd. Announces Executive Changes	15/02	CI
Compugen Names Alberto Sessa CFO	12/22/12	MT
Compugen Ltd. Announces Resignation of Ari Krashin as Chief Operating Officer in August 2022	04/22/04	CI
Compugen Ltd. Announces Resignation of Ari Krashin as Chief Financial Officer in August 2022	04/22/04	CI
Compugen CFO, COO Ari Krashin to Step Down in August	10/22/10	MT
Compugen Announces Ari Krashin Departure as Chief Operating Officer	10/22/10	CI
Compugen Ltd. Announces Board Changes	24/22/24	CI
Compugen Ltd. Announces Board Changes	30/20/30	CI
Compugen Ltd. Announces Appointment of Oliver Froescheis as Senior Vice President, Corporate and Business Development	08/20/08	CI
Compugen Ltd. Announces Board Changes	02/19/02	CI
Compugen Ltd. Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors	05/18/05	CI
Compugen Ltd. Announces Board Changes	11/18/11	CI
Dov Hershberg Resigns as Director of Compugen Ltd	04/18/04	CI
Compugen Ltd. Appoints Henry Adewoye as Chief Medical Officer	26/18/26	CI
Compugen Ltd. Announces Management Changes	01/18/01	CI
Joshua Shemer Resigns as Director of Compugen Ltd	18/17/18	CI
Compugen Ltd. Appoints Paul Sekhri as Director and Chairman of the Board, Effective October 2, 2017	02/17/02	CI
Compugen Ltd Appoints Michal Preminger to Board of Directors	25/17/25	CI
Compugen Adds Miriam Merad to Scientific Advisory Board	08/17/08	CI

No results for this search